For the Media
Dr. Amanda Paulovich is a member of Fred Hutch's Clinical Research Division. Her research is focused on the development of technologies and strategies for translation of novel diagnostics, and relieving a prohibitive roadblock in biomedical research: a lack of validated and standardized tools for quantifying proteins. The inability to quantitatively measure most human proteins is a major obstacle to clinical translation of biomarkers and the development of new therapeutics.
Overview of Amanda Paulovich's Research
The Paulovich Laboratory's ultimate goals are to use this technology to identify novel therapeutic targets and to understand the underlying molecular mechanisms and human phenotypic variation of the cellular DNA damage response.
Amanda Paulovich - Brief Curriculum Vitae
Appointments, affiliations and researcher interests
Amanda Paulovich Featured Researcher Profile
Oncologist and cancer geneticist — Paulovich's lab develops technologies aimed at rapidly screening large numbers of telltale proteins—known as "biomarkers"—for clues that may indicate the earliest stages of cancer and other diseases.
The interdisciplinary team aims to foster the uptake of proteomic technologies in a rigorous fashion to enable basic and clinical studies and ultimately improve the quality of patient care.
Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.